Lung Cancer Biomarkers and Screening
Recruiting · NCT00301119 · Observational (researchers observe without assigning treatment) · Lead sponsor: NYU Langone Health
View the official record on ClinicalTrials.gov →What this trial is about
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Who can take part
Age range
50 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Eligibility criteria (as published)
DISEASE CHARACTERISTICS:
* Screening Cohort
* At high- or low-risk for lung cancer
* Smoking history ≥ 20 pack years\*
* With or without workplace exposure to asbestos
* NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older
* Rule-Out Lung cancer group
* Referred for evaluation of suspicious nodules with 1 of the following diagnoses:
* Lung cancer
* Nonmalignant nodules (control group)
PATIENT CHARACTERISTICS:
* Not pregnant
* No prior malignancy except nonmelanoma skin cancer
PRIOR CONCURRENT THERAPY:
* Not specified
Where it is running
1 location listed across 1 US state.
- NYU Cancer Institute at New York University Medical Center - New York, New York, United States